These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 9719247)
41. Aerosolized pentamidine in HIV. Promising new treatment for Pneumocystis carinii pneumonia. Sarti GM Postgrad Med; 1989 Aug; 86(2):54-6, 59-60, 63, passim. PubMed ID: 2666972 [TBL] [Abstract][Full Text] [Related]
42. Comparison of pentamidine isethionate and trimethoprim-sulfamethoxazole in the treatment of Pneumocystis carinii pneumonia. Hughes WT; Feldman S; Chaudhary SC; Ossi MJ; Cox F; Sanyal SK J Pediatr; 1978 Feb; 92(2):285-91. PubMed ID: 304478 [TBL] [Abstract][Full Text] [Related]
43. Trimethoprim/sulfamethoxazole and metabolic acidosis in HIV-infected patients. Porras MC; Lecumberri JN; Castrillón JL Ann Pharmacother; 1998 Feb; 32(2):185-9. PubMed ID: 9496402 [TBL] [Abstract][Full Text] [Related]
44. Deterioration of the immune response induced by sulfamethoxazole-trimethoprim in a rheumatoid arthritis patient with Pneumocystis jirovecii pneumonia. Gochi M; Takayanagi N; Ishiguro T; Miyahara Y; Yanagisawa T; Shimizu Y; Sugita Y Intern Med; 2014; 53(11):1137-41. PubMed ID: 24881737 [TBL] [Abstract][Full Text] [Related]
45. Co-trimoxazole red cell aplasia in leukaemia. Unter CE; Abbott GD Arch Dis Child; 1987 Jan; 62(1):85-7. PubMed ID: 3101617 [TBL] [Abstract][Full Text] [Related]
46. Trimethoprim-sulfamethoxazole in the treatment of adults with pneumonia due to Pneumocystis carinii. Young LS Rev Infect Dis; 1982; 4(2):608-13. PubMed ID: 6981177 [TBL] [Abstract][Full Text] [Related]
47. Treatment of Pneumocystis jirovecii pneumonia in HIV-infected patients: a review. Huang YS; Yang JJ; Lee NY; Chen GJ; Ko WC; Sun HY; Hung CC Expert Rev Anti Infect Ther; 2017 Sep; 15(9):873-892. PubMed ID: 28782390 [TBL] [Abstract][Full Text] [Related]
48. Comparison of three regimens for treatment of mild to moderate Pneumocystis carinii pneumonia in patients with AIDS. A double-blind, randomized, trial of oral trimethoprim-sulfamethoxazole, dapsone-trimethoprim, and clindamycin-primaquine. ACTG 108 Study Group. Safrin S; Finkelstein DM; Feinberg J; Frame P; Simpson G; Wu A; Cheung T; Soeiro R; Hojczyk P; Black JR Ann Intern Med; 1996 May; 124(9):792-802. PubMed ID: 8610948 [TBL] [Abstract][Full Text] [Related]
49. Drug treatment of pneumonia due to Pneumocystis carinii. Huffman D; Musher DM; Reuben AG Tex Med; 1987 Feb; 83(2):27-30. PubMed ID: 3493548 [No Abstract] [Full Text] [Related]
50. Comparison of atovaquone (566C80) with trimethoprim-sulfamethoxazole to treat Pneumocystis carinii pneumonia in patients with AIDS. Hughes W; Leoung G; Kramer F; Bozzette SA; Safrin S; Frame P; Clumeck N; Masur H; Lancaster D; Chan C N Engl J Med; 1993 May; 328(21):1521-7. PubMed ID: 8479489 [TBL] [Abstract][Full Text] [Related]
51. Clinical features of Pneumocystis pneumonia in the acquired immune deficiency syndrome. Engelberg LA; Lerner CW; Tapper ML Am Rev Respir Dis; 1984 Oct; 130(4):689-94. PubMed ID: 6333195 [TBL] [Abstract][Full Text] [Related]
52. Successful intermittent prophylaxis with trimethoprim/sulfamethoxazole 2 days per week for Pneumocystis carinii (jiroveci) pneumonia in pediatric oncology patients. Lindemulder S; Albano E Pediatrics; 2007 Jul; 120(1):e47-51. PubMed ID: 17606548 [TBL] [Abstract][Full Text] [Related]
53. Therapeutic failure of trimethoprim/sulfamethoxazole in the treatment of Pneumocystis carinii pneumonia. al-Tawfiq JA; Sorensen SJ; Cushing HE Ann Pharmacother; 1999 Apr; 33(4):413-5. PubMed ID: 10332530 [TBL] [Abstract][Full Text] [Related]
54. Trimethoprim/sulfamethoxazole-induced tremor in a patient with AIDS. Slavik RS; Rybak MJ; Lerner SA Ann Pharmacother; 1998 Feb; 32(2):189-92. PubMed ID: 9496403 [TBL] [Abstract][Full Text] [Related]
55. Correlation of organism burden and alveolar macrophage counts during infection with Pneumocystis carinii and recovery. Lasbury ME; Durant PJ; Bartlett MS; Smith JW; Lee CH Clin Diagn Lab Immunol; 2003 Mar; 10(2):293-302. PubMed ID: 12626457 [TBL] [Abstract][Full Text] [Related]
56. [The importance of Pneumocystis carinii infection in patients with acute respiratory distress syndrome]. Härtel B; Knoch M; Müller E; Mutters R; Lennartz H Anasthesiol Intensivmed Notfallmed Schmerzther; 1991 Apr; 26(2):102-4. PubMed ID: 1873409 [TBL] [Abstract][Full Text] [Related]
57. Reaction after re-exposure to trimethoprim-sulfamethoxazole. Ulstad DR; Ampel NM; Shon BY; Galgiani JN; Cutcher AB Chest; 1989 Apr; 95(4):937-8. PubMed ID: 2784374 [No Abstract] [Full Text] [Related]
58. Resistance to trimethoprim-sulfamethoxazole in the treatment of Pneumocystis carinii pneumonia. Implication of folinic acid. Nunn PP; Allistone JC Chest; 1984 Jul; 86(1):149-50. PubMed ID: 6610537 [TBL] [Abstract][Full Text] [Related]
59. Pneumocystis jiroveci pneumonia and pneumomediastinum in an anti-TNFalpha naive patient with ulcerative colitis. Lee JC; Bell DC; Guinness RM; Ahmad T World J Gastroenterol; 2009 Apr; 15(15):1897-900. PubMed ID: 19370790 [TBL] [Abstract][Full Text] [Related]
60. Trimetrexate with leucovorin versus trimethoprim-sulfamethoxazole for moderate to severe episodes of Pneumocystis carinii pneumonia in patients with AIDS: a prospective, controlled multicenter investigation of the AIDS Clinical Trials Group Protocol 029/031. Sattler FR; Frame P; Davis R; Nichols L; Shelton B; Akil B; Baughman R; Hughlett C; Weiss W; Boylen CT J Infect Dis; 1994 Jul; 170(1):165-72. PubMed ID: 8014493 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]